On subtype analysis of breast cancer based on TCGA and GEO databases, MTHFD2 expression was found to be higher in the basal (TNBC) and human epidermal receptor 2-amplification subtypes than in the luminal subtype (Figures 4M, N). Here, MTHFD2 is linked to breast cancer.